This webinar was recorded on 23 April 2020
COVID-19 is not only likely to impact your health, its effects are more far-reaching with disruptions to the supply chain, manufacturing output resulting in an overall decline in the economy. The Gross Domestic Product (“GDP”) for Singapore has been revised downward to between -4% to -1%. The negative impact on the economy is also going to have a knock-on effect on the profitability of any company.
How are these factors likely to impact the transfer prices that have been established by a company? And how should one be prepared for a transfer pricing scrutiny in the years that follow?
These are the key questions that will be addressed by this webinar.
Dr Sowmya Varadharajan is a Director at IC Advisors Pte Ltd, a firm that helps companies design and document appropriate transfer pricing strategies and approaches for their related party transactions. Having been trained in the U.S. on international tax and transfer pricing issues through blue-chip corporations, Sowmya now applies her transfer pricing training to transfer pricing issues in the Asia Pacific region.
Sowmya has extensive experience in the high technology/semiconductor as well as pharmaceutical/biomedical industries. In addition to transfer pricing, she is also skilled in IP valuation. With the growth in transfer pricing related audits in the Asia Pacific region, Sowmya has assisted clients in India, China, Malaysia, Indonesia and Singapore in defending their transfer pricing arrangements with tax authorities.
Sowmya is an economist with Ph.D. in Economics from Cornell University and has more than 17 years of transfer pricing consulting experience.